Auto-Antibodies in Juvenile Myositis

This webinar will introduce you to the concept of Myositis Specific Antibodies, or MSAs.

What will you get from this webinar?

  • Learn how to have MSAs tested and the value of having them tested.
  • Learn how myositis-specific antibodies have improved our understanding of myositis by leading to the identification of certain clinical patterns that help doctors understand how the disease might progress in patients with certain MSAs.
  • Learn the value in understanding MSA’s to help further personalize treatment options that your clinical team may consider.

The webinar is presented by:

  • Sara Sabbagh, D.O., Clinical Fellow, Muscle Disease Unit at the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (NIH).

What is Juvenile Myositis?

Juvenile myositis, including juvenile dermatomyositis and juvenile polymyositis, is a group of rare and life-threatening autoimmune diseases, in which the body’s immune system attacks its own cells and tissues.

Treatment Plans for Juvenile Myositis

A treatment plan is based on many factors, including the severity and expression of the juvenile dermatomyositis (JDM). Each case is different and the symptoms can change over time.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.